Posted on

what is cannabis oil made out of

Hemp seed oil is also extracted from the hemp plant, but it differs from hemp oil in a few key ways. While it is nutrient-dense like CBD oil, hemp seed oil lacks cannabinoids at a level high enough to be effective as a CBD product. Using hemp seed oil is much more similar to eating hemp-based foods than using CBD oil products.

RSHO® is an award-winning brand that specializes in CBD oil concentrate products. All RSHO® products are typically available in four different varieties and all feature high concentrations of CBD. Some RSHO® CBD oil products include:

Hemp and marijuana are both types of cannabis plants. That means that both hemp oil and marijuana oil are forms of cannabis oil. Despite being members of the same family of plants, marijuana and hemp have some important differences. To best understand the differences between the different types of cannabis oil, it helps to know more about the cannabis family of plants.

Hemp Seed Oil

A supercritical CO2 extraction method produces a dark green oil that is often packaged and sold to promote wellness, due to its nutrient and cannabinoid content. This raw hemp oil can also be combined with other ingredients to be formulated into a range of consumer CBD products, like tinctures, edibles, and capsules.

Cannabis oil is a term applied to any type of extract of the cannabis plant, including extracts from both marijuana and hemp. The goal of the cannabis oil extraction process is to remove the plant’s naturally thick, viscous oil from dried or fresh cannabis.

Maine, Michigan, Illinois, Massachusetts, and Vermont have also legalized recreational marijuana. However, as of now, there are no legal dispensaries licensed in these markets, so consumers aren’t able to purchase marijuana yet.

Hemp oil, on the other hand, is federally legal following the 2018 passing of the Farm Bill. The bill made it so that hemp was no longer a controlled substance, making the cultivation, sale, and use of hemp products completely legal on a federal level.

Cannabis oils are extracts from cannabis plants. Unprocessed, they contain the same 100 or so active ingredients as the plants, but the balance of compounds depends on the specific plants the oil comes from. The two main active substances in cannabis plants are cannabidiol, or CBD, and delta-9 tetrahydrocannabinol, or THC. Oil extracted from hemp plants can contain a lot of CBD, while oil from skunk plants will contain far more THC. THC produces the high that recreational cannabis users seek, while oils for medical use contain mostly CBD.

Other forms of cannabis are solid and are usually sold either as resin or dried plant material. In commercially-produced medical cannabis oils, the concentrations of CBD and THC tend to be well-controlled, which makes it easy to calculate doses.

How is it different to cannabis?

CBD is an anticonvulsant, and some other compounds in the plant, including THC and cannabidivarin, may be too. There is good evidence from clinical trials in the US and Europe that pharmaceutical preparations of CBD can treat two severe forms of childhood epilepsy known as Dravet syndrome and Lennox-Gastaut syndrome. Both forms of epilepsy often fail to improve with existing epilepsy drugs. CBD is generally considered safe, but some trials have reported side effects including dry mouth, lightheadedness and altered liver enzyme activity.

Cannabis oil can only be sold legally in Britain if it contains less than 0.05% THC. But the nation’s medicines regulator, the MHRA, announced recently that even pure CBD could not be sold as a medicine without first going through the usual clinical testing and safety checks required for all new medicines. This month, the US Food and Drug Administration will consider the approval of Epidiolex, a CBD-based medicine from GW Pharmaceuticals, which has completed such clinical trials. The European Medicines Agency (EMA) will rule on the drug early next year. If the EMA approves Epidiolex, it could be available to prescribe to named patients in Britain next year, Brexit notwithstanding.

Four drugs based on cannabis compounds are already on the market in Europe. Among them are Nabilone, a synthetic compound that mimics THC, is prescribed for nausea and vomiting caused by chemotherapy, and Sativex, an oil that contains equal parts THC and CBD, is used to treat muscle spasms in multiple sclerosis. Both contain too much THC to administer to children. “The only medicines that are approved in the UK would get children stoned,” said David Nutt, professor of neuropsychopharmacology at Imperial College, London.